The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces growing concerns about monopolies. A few dominant companies control a significant percentage of the market, potentially hampering competition and driving up prices for consumers. This concern raises worries about the long-term impact on patient access to a… Read More